Back to Search
GREGORY HELBIG, M.D.
M.D.
Neurological Surgery Physician
NPI: 1972761211IndividualAccepts Medicare
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
A114866(CA)
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
A114866(CA)
CMS Specialties
PrimaryNEUROSURGERY
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 2004
Research & Publications (16)
Elastin metabolism is disrupted in patients after allogeneic hematopoietic stem cell transplantation (alloHSCT) for acute and chronic myeloid leukemia.
PMID 18971876·Med Sci Monit·2008
8-other
A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients.
PMID 18307562·Br J Haematol·2008
3-trial
Interferon alpha induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation.
PMID 18024388·Haematologica·2007
5-case
Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
PMID 17486341·Ann Hematol·2007
8-other
The achievement of complete molecular remission after autologous stem cell transplantation for T-cell lymphoma with associated hypereosinophilia, rare aberration t(6;11) and elevated IL-4 and IgE.
PMID 16923526·Haematologica·2006
5-case
[Oncogene Fip1-likeL/PDGFRalpha as a target for imatinib in patients with hypereosinophilic syndrome and chronic eosinophilic leukemia. A novel look at pathogenesis and therapy].
PMID 16479834·Pol Arch Med Wewn·2005
6-review
Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
PMID 16266924·Haematologica·2005
5-case
[Ras signaling pathway as a target for farnesyltransferase inhibitors--a new, promising prospects in the treatment for malignant disorders].
PMID 15765763·Wiad Lek·2004
6-review
Clinical significance of elastin turnover--focus on diseases affecting elastic fibres.
PMID 15631192·Wiad Lek·2004
6-review
Weekly imatinib dosage for chronic eosinophilic leukaemia expressing FIP1L1-PDGFRA fusion transcript: extended follow-up.
PMID 19120352·Br J Haematol·2009
8-other
Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.
PMID 18850018·Bone Marrow Transplant·2009
8-other
Screening for JAK2 V617F point mutation in patients with hypereosinophilic syndrome-in response to 'Hypereosinophilic syndrome: another face of janus?' by Dahabreh et al. published in Leukemia Research, in press.
PMID 18466967·Leuk Res·2009
8-other
The results of imatinib therapy for patients with primary eosinophilic disorders.
PMID 16608506·Eur J Haematol·2006
8-other
[Preliminary results of monotherapy with thalidomide in recurrent and treatment resistant cases of multiple myeloma].
PMID 14526479·Wiad Lek·2003
3-trial
NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
PMID 12690099·J Biol Chem·2003
7-preclinical
A laboratory comparison of the efficacy of battery-operated, non-rechargeable power toothbrushes.
PMID 12003485·Am J Dent·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4016 DALE RD
MODESTO, CA 95356 - Phone
- (209) 571-0288
Quick Facts
- NPI
- 1972761211
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 22
- Publications
- 16
Are you this provider?
Claim Your Profile